These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 15904908)

  • 21. Increased soluble IL-2 receptor levels during interferon and ribavirin treatment are associated with a good response in genotype 2a/2b patients with chronic hepatitis C.
    Abe S; Narita R; Matsuhashi T; Oto T; Tabaru A; Otsuki M
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):373-8. PubMed ID: 18403937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peginterferon {alpha}-2b and ribavirin therapy in chronic hepatitis C genotype 4: impact of treatment duration and viral kinetics on sustained virological response.
    Kamal SM; El Tawil AA; Nakano T; He Q; Rasenack J; Hakam SA; Saleh WA; Ismail A; Aziz AA; Madwar MA
    Gut; 2005 Jun; 54(6):858-66. PubMed ID: 15888797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peginterferon alpha-2a (40 KD) plus ribavirin for the treatment of chronic hepatitis C in Japanese patients.
    Kuboki M; Iino S; Okuno T; Omata M; Kiyosawa K; Kumada H; Hayashi N; Sakai T
    J Gastroenterol Hepatol; 2007 May; 22(5):645-52. PubMed ID: 17444850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: a placebo-controlled trial.
    Berg T; Kronenberger B; Hinrichsen H; Gerlach T; Buggisch P; Herrmann E; Spengler U; Goeser T; Nasser S; Wursthorn K; Pape GR; Hopf U; Zeuzem S
    Hepatology; 2003 Jun; 37(6):1359-67. PubMed ID: 12774015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic hepatitis C. Genotypes and response to anti-viral therapy among Saudi patients.
    Al-Traif I; Handoo FA; Al-Jumah A; Al-Nasser M
    Saudi Med J; 2004 Dec; 25(12):1935-8. PubMed ID: 15711670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the exponential decay slope between PEG-IFN alfa-2b/ribavirin and IFN alfa-2b/ribavirin combination therapy in patients with chronic hepatitis C genotype 1b infection and a high viral load.
    Izumi N; Asahina Y; Kurosaki M; Uchihara M; Nishimura Y; Inoue K; Ueda K; Tsuchiya K; Hamano K; Itakura J; Miyake S
    Intervirology; 2004; 47(2):102-7. PubMed ID: 15192274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cutaneous reactions induced by pegylated-interferon plus ribavirin combination therapy in a patient with chronic hepatitis C].
    Enjoji M; Dainichi T; Gondo H; Urabe K
    Fukuoka Igaku Zasshi; 2007 Sep; 98(9):353-6. PubMed ID: 17974079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pilot study of low-dose interleukin-2, pegylated interferon-alpha 2b, and ribavirin for the treatment of hepatitis C virus infection in patients with HIV infection.
    Glesby MJ; Bassett R; Alston-Smith B; Fichtenbaum C; Jacobson EL; Brass C; Owens S; Sulkowski M; Race EM; Sherman KE;
    J Infect Dis; 2005 Mar; 191(5):686-93. PubMed ID: 15688281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of sarcoidosis during interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C--a case report and review of the literature.
    Bolukbas C; Bolukbas FF; Kebdir T; Canayaz L; Dalay AR; Kilic G; Ovunc O
    Acta Gastroenterol Belg; 2005; 68(4):432-4. PubMed ID: 16432996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of low-dose pegylated interferon versus standard high-dose pegylated interferon in combination with ribavirin in patients with chronic hepatitis C with genotype 3: an Indian experience.
    Sood A; Midha V; Hissar S; Kumar M; Suneetha PV; Bansal M; Sood N; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2008 Feb; 23(2):203-7. PubMed ID: 17645472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The possible role of zinc and metallothionein in the liver on the therapeutic effect of IFN-alpha to hepatitis C patients.
    Nagamine T; Takagi H; Hashimoto Y; Takayama H; Shimoda R; Nomura N; Suzuki K; Mori M; Nakajima K
    Biol Trace Elem Res; 1997; 58(1-2):65-76. PubMed ID: 9363321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of eicosapentaenoic acid supplementation in the treatment of chronic hepatitis C patients.
    Tomioka K; Kakibuchi N; Murakami Y; Kawakami T; Takaguchi K; Kita K; Okita M
    J Nutr Sci Vitaminol (Tokyo); 2005 Dec; 51(6):419-25. PubMed ID: 16521701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zinc gluconate in the treatment of dysgeusia--a randomized clinical trial.
    Heckmann SM; Hujoel P; Habiger S; Friess W; Wichmann M; Heckmann JG; Hummel T
    J Dent Res; 2005 Jan; 84(1):35-8. PubMed ID: 15615872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effect of Zinc Gluconate Supplementation on Symptoms and Tongue Epithelium Regeneration in Non-psoriatic Patients with Migratory Glossitis.
    Čanković M; Bokor-Bratić M; Marinoski J; Stilinović N
    Acta Dermatovenerol Croat; 2018 Jun; 26(2):125-132. PubMed ID: 29989868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Otolaryngology: Medical Treatment of Traumatic Anosmia.
    Amedee RG
    Am J Rhinol Allergy; 2015; 29(5):401. PubMed ID: 26358356
    [No Abstract]   [Full Text] [Related]  

  • 36. Zinc: A complementary factor in the treatment of chronic hepatitis C? (Review).
    Grüngreiff K; Reinhold D
    Mol Med Rep; 2010; 3(3):371-5. PubMed ID: 21472249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triple therapy of interferon and ribavirin with zinc supplementation for patients with chronic hepatitis C: a randomized controlled clinical trial.
    Suzuki H; Takagi H; Sohara N; Kanda D; Kakizaki S; Sato K; Mori M;
    World J Gastroenterol; 2006 Feb; 12(8):1265-9. PubMed ID: 16534882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral activity of zinc against hepatitis viruses: current status and future prospects.
    Kumar S; Ansari S; Narayanan S; Ranjith-Kumar CT; Surjit M
    Front Microbiol; 2023; 14():1218654. PubMed ID: 37908540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zinc in Human Health and Infectious Diseases.
    Maywald M; Rink L
    Biomolecules; 2022 Nov; 12(12):. PubMed ID: 36551176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between zinc deficiency and infectious complications in patients with hepatitis B virus-related acute-on-chronic liver failure.
    Li X; Wang L; He N; Zhang Y; Pang J; Wang H; Yu M; Mei Y; Peng L; Xu W
    Gastroenterol Rep (Oxf); 2022; 10():goac066. PubMed ID: 36381223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.